financetom
Business
financetom
/
Business
/
Sodexo cuts 2026 targets as new CEO gears to tackle long-standing issues
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sodexo cuts 2026 targets as new CEO gears to tackle long-standing issues
Apr 10, 2026 3:10 AM

April 10 (Reuters) - French food caterer Sodexo slashed its annual sales and profitability targets on Friday, citing execution challenges and its management's review of contracts and assets, which sent its shares falling 13%.

The group sees organic revenue growth of between 0.5% and 1% this year, down from the previously expected 1.5% to 2.5%. It expects its underlying operating margin to be clearly lower at between 3.2% and 3.4%, having earlier guided for a slight decline from last year's 4.7%.

"Shares should react negatively given a bigger-than-expected earnings reset and deteriorating commercial performance in H1," Jefferies analysts said in their first take on the half-year report.

Sodexo's shares have lost around 40% of their value in the past two years, clearly underperforming key food services rivals Compass and Aramark ( ARMK ), an issue new CEO Thierry Delaporte highlighted in his comments to the press.

"We have consistently underperformed compared to the market and our competitors," Delaporte told journalists. "The causes are deep-rooted and long-standing."

Delaporte, who replaced Sophie Bellon in November, said Sodexo had underinvested in key skills and lacked consistency in its performance and forecasts.

He also pointed to issues in commercial intensity, priority management and an overly cumbersome decision-making structure, all of which he aims to tackle.

AlphaValue analyst Yi Zhong said she expected Sodexo to increase capital spending to match its peers, while potentially lowering dividend payouts.

WEAKNESS IN NORTH AMERICA

Sodexo's revenue fell 3.7% to 12.02 billion euros ($14.05 billion) in the first half of its financial year, weighed down by the effects of converting U.S. dollars into euros, and as the North American business continued to struggle. That was some 60 million euros below analysts' consensus.

Rising competition from Aramark ( ARMK ) may explain some of the troubles in the U.S. markets, Morningstar analyst Ben Slupecki said.

"Sodexo has failed to adjust, has been caught flat-footed, and has seen net new deceleration into losses in the first half of the year," Slupecki told Reuters.

($1 = 0.8552 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US considering revoking authorizations for Samsung, Hynix, TSMC in China - sources
US considering revoking authorizations for Samsung, Hynix, TSMC in China - sources
Jun 20, 2025
* White House views plan as a contingency if trade truce fails * Move would make it harder for foreign chipmakers to operate in China * Move would be a gift to domestic Chinese competitors (Changes sourcing, adds comments on motive, chances throughout) By Karen Freifeld and Alexandra Alper June 20 (Reuters) - The Department of Commerce is considering revoking...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
BRIEF-Spectral IP Now Estimates IPO Price Between $4.00 And $5.00 Per Share
BRIEF-Spectral IP Now Estimates IPO Price Between $4.00 And $5.00 Per Share
Jun 20, 2025
June 21 (Reuters) - Spectral IP Inc: * SPECTRAL IP INC - IPO PRICE NOW ESTIMATED BETWEEN $4.00 AND $5.00 PER SHARE - SEC FILING Source text: Further company coverage: ...
Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says
Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says
Jun 20, 2025
By Bhanvi Satija June 20 (Reuters) - Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly ( LLY ) and Novo Nordisk could generate more than $30 billion in sales by 2035, analysts at TD Cowen said on Friday. About a dozen companies are racing to develop such therapies, most of which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved